361 Capital’s Molina Healthcare MOH Stock Holding History

361 Capital’s Portfolio MOH Stock Details MOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,627	Closed	-$837K	–	377
2019 Q3	$837K	Sell	7,627 -161	-2%	-$20.9K	0.15%	226
2019 Q2	$1.11M	Buy	+7,788	New	+$1.07M	0.2%	205
2017 Q1	–	Sell	-13,502	Closed	-$733K	–	190
2016 Q4	$733K	Buy	+13,502	New	+$739K	0.17%	99

Other funds holding MOH

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

361 Capital's MOH Position: Q4 2019 in Review

361 Capital sold out of Molina Healthcare (MOH) in Q4 2019, closing a stake of 7,627 shares — an estimated $837K sold.

361 Capital first reported a position in MOH in Q4 2016 and held it in 3 quarters. The position peaked at $1.11M in Q2 2019. 325 funds tracked by Wall St. Rank hold MOH as of Q4 2019.

361 Capital reported no remaining Molina Healthcare position as of Q4 2019 after selling out during the quarter.
361 Capital sold 7,627 Molina Healthcare shares in Q4 2019, an estimated $837K.
361 Capital first reported a position in Molina Healthcare in Q4 2016 and held it in 3 quarters.
361 Capital's Molina Healthcare position peaked at $1.11M in Q2 2019.
325 funds tracked by Wall St. Rank held Molina Healthcare as of Q4 2019.

Based on 361 Capital's 13F filing for Q4 2019, filed 13 Feb 2020.